EIR Patheon Pharmaceuticals Mar 2010

Christopher Middendorf FDA, Nicholas Paulin FDA$595.00 - Available Now

FDA investigators audited the Patheon Pharmaceuticals - Cincinnati, OH, United States facility and issued inspectional observation (via FDA 483) on 24 Mar 2010.

Product details

  • Category:
  • Inspection end: 24 Mar 2010
  • Location: Cincinnati, United States
  • FEI: 1510437
Add To Cart